DK0718295T3 - Lactoner med antioxiderende og hypolipidæmisk virkning, hvilke lactoner er nyttige i terapien af atherosklerose - Google Patents

Lactoner med antioxiderende og hypolipidæmisk virkning, hvilke lactoner er nyttige i terapien af atherosklerose

Info

Publication number
DK0718295T3
DK0718295T3 DK95118629T DK95118629T DK0718295T3 DK 0718295 T3 DK0718295 T3 DK 0718295T3 DK 95118629 T DK95118629 T DK 95118629T DK 95118629 T DK95118629 T DK 95118629T DK 0718295 T3 DK0718295 T3 DK 0718295T3
Authority
DK
Denmark
Prior art keywords
lactones
atherosclerosis
useful
antioxidant
therapy
Prior art date
Application number
DK95118629T
Other languages
English (en)
Inventor
Goffredo Rosini
Claudia Baldazzi
Eleonora Romagnoli
Stefano Saguatti
Silvano Piani
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of DK0718295T3 publication Critical patent/DK0718295T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DK95118629T 1994-12-21 1995-11-27 Lactoner med antioxiderende og hypolipidæmisk virkning, hvilke lactoner er nyttige i terapien af atherosklerose DK0718295T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Publications (1)

Publication Number Publication Date
DK0718295T3 true DK0718295T3 (da) 1999-01-11

Family

ID=11340165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95118629T DK0718295T3 (da) 1994-12-21 1995-11-27 Lactoner med antioxiderende og hypolipidæmisk virkning, hvilke lactoner er nyttige i terapien af atherosklerose

Country Status (9)

Country Link
US (1) US5608084A (da)
EP (1) EP0718295B1 (da)
JP (1) JP2820652B2 (da)
AT (1) ATE165354T1 (da)
DE (1) DE69502168T2 (da)
DK (1) DK0718295T3 (da)
ES (1) ES2115308T3 (da)
GR (1) GR3026702T3 (da)
IT (1) IT1274355B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680340B2 (en) * 2000-08-21 2004-01-20 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
DE10261067A1 (de) * 2002-12-24 2004-08-05 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4665091A (en) * 1985-11-04 1987-05-12 Merck & Co., Inc. Macrocyclic lactone HMG-CoA reductase inhibitors
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
JPH08231535A (ja) 1996-09-10
IT1274355B (it) 1997-07-17
GR3026702T3 (en) 1998-07-31
EP0718295B1 (en) 1998-04-22
US5608084A (en) 1997-03-04
EP0718295A1 (en) 1996-06-26
DE69502168D1 (de) 1998-05-28
JP2820652B2 (ja) 1998-11-05
ES2115308T3 (es) 1998-06-16
DE69502168T2 (de) 1998-08-13
ATE165354T1 (de) 1998-05-15
ITBO940562A1 (it) 1996-06-21
ITBO940562A0 (it) 1994-12-21

Similar Documents

Publication Publication Date Title
CY1112024T1 (el) Αναστολεις υποδοχεων adp αιμοπεταλιων
EA200000888A1 (ru) Производные желчных кислот
NO20031001L (no) Polyarylkarboksamider nyttige som lipidsenkende midler
IS2125B (is) Frumuviðloðunar-bælandi bólgu-eyðandi og ónæmisbælandi efnasambönd
NO20060409L (no) Forbindelser for inflammasjon og immun-relaterte anvendelser
DE60114994D1 (de) Blutplättchen-adp-rezeptor-inhibitoren
ATE511858T1 (de) 2,4,6-triamino-1,3,5-triazin-derivat
EA200100707A1 (ru) Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и производных фибриновой кислоты для сердечно-сосудистых показаний
FR2789615B1 (fr) Traitement de pieces metalliques par choc laser
NO995544D0 (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
WO2002022577A3 (en) Hydroxamate derivatives useful as deacetylase inhibitors
ECSP024384A (es) INHIBIDORES DE HMG - CoA REDUCTASA Y METODO
EA200100703A1 (ru) Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и производных никотиновой кислоты для сердечно-сосудистых показаний
ES2183882T3 (es) Inhibidores de trombina.
AU4025599A (en) Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases
EA200201175A1 (ru) Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза
DE60324544D1 (de) Muskarin antagonisten
DK0831721T3 (da) Dej- og paneringsbelagte levnedsmiddelsammensætninger ved anvendelse af calciumpectiner
NO20054778L (no) Farmasoytiske sammensetninger som innbefatter en kombinasjon av rapamycin eller dets derivat og pimecrolimus for behandling av inflamasjon- og immunologisk-medierte sykdommer
DK1313740T3 (da) Prodrugs af imidazopyridinderivater
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
DK0718295T3 (da) Lactoner med antioxiderende og hypolipidæmisk virkning, hvilke lactoner er nyttige i terapien af atherosklerose
ID25478A (id) Agonis 5-ht1f
DE69824901D1 (de) Cholesterin Esterase Inhibitoren